LeadIQ logo
Learn more at LeadIQ.com

Insights

Partnership Potential cellvie Inc. has recently partnered with CSEM Engimmune Therapeutics AG and secured an Innosuisse grant to advance their mitochondria-based therapy platform. Exploring collaboration opportunities with such partners could lead to mutually beneficial ventures.

Expansion Opportunities With a recent office expansion to Zürich, Switzerland, cellvie Inc. is positioning itself for growth. Leveraging this expansion as a springboard, exploring market opportunities in the Swiss biotechnology sector could be fruitful for further business development.

Investment Interest Having secured a $5.5 million investment round led by Taiho Ventures and KIZOO Technology Capital GmbH, cellvie Inc. showcases investor confidence. Engaging with similar investment firms or exploring additional funding rounds could fuel the company's growth trajectory.

Recognition Advantage Achieving accolades such as the De Vigier Entrepreneurship Award and the MedTech Innovator Value Award, cellvie Inc. has garnered recognition in the industry. Utilizing these awards as a credibility boost in sales pitches and marketing efforts could enhance the company's reputation.

Competitive Positioning In an industry with similar companies like Synthace, Envisagenics, and CAMP4 Therapeutics, cellvie Inc.'s focus on Therapeutic Mitochondria Transplantation sets it apart. Highlighting this unique selling point in competitive analyses and client comparisons could differentiate the company in the market.

cellvie Tech Stack

cellvie uses 6 technology products and services including Font Awesome, Google Font API, jQuery, and more. Explore cellvie's tech stack below.

  • Font Awesome
    Font Scripts
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • PWA
    Miscellaneous
  • Bootstrap
    UI Frameworks
  • Nginx
    Web Servers

cellvie's Email Address Formats

cellvie uses at least 1 format(s):
cellvie Email FormatsExamplePercentage
FL@cellvie.bioJD@cellvie.bio
48%
LFirst@cellvie.bioDJohn@cellvie.bio
2%
FL@cellvie.bioJD@cellvie.bio
48%
LFirst@cellvie.bioDJohn@cellvie.bio
2%

Frequently Asked Questions

Where is cellvie's headquarters located?

Minus sign iconPlus sign iconcellvie's main headquarters is located at Zuerich, CH. The company has employees across 2 continents, including EuropeNorth America.

What is cellvie's official website and social media links?

Minus sign iconPlus sign iconcellvie's official website is cellvie.bio and has social profiles on LinkedIn.

What is cellvie's SIC code NAICS code?

Minus sign iconPlus sign iconcellvie's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does cellvie have currently?

Minus sign iconPlus sign iconAs of April 2025, cellvie has approximately 14 employees across 2 continents, including EuropeNorth America. Key team members include Chief Scientific Officer: S. H.Chief Operations Officer: M. B.Founder & Ceo: A. S.. Explore cellvie's employee directory with LeadIQ.

What industry does cellvie belong to?

Minus sign iconPlus sign iconcellvie operates in the Biotechnology Research industry.

What technology does cellvie use?

Minus sign iconPlus sign iconcellvie's tech stack includes Font AwesomeGoogle Font APIjQueryPWABootstrapNginx.

What is cellvie's email format?

Minus sign iconPlus sign iconcellvie's email format typically follows the pattern of . Find more cellvie email formats with LeadIQ.

How much funding has cellvie raised to date?

Minus sign iconPlus sign icon As of April 2025, cellvie has raised $5.5M in funding. The last funding round occurred on Feb 06, 2023 for $5.5M.

When was cellvie founded?

Minus sign iconPlus sign iconcellvie was founded in 2018.
cellvie

cellvie

Biotechnology ResearchZuerich, Switzerland11-50 Employees

cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT).

The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. 

Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation.

Section iconCompany Overview

Headquarters
Zuerich, CH
Website
cellvie.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5.5M

    cellvie has raised a total of $5.5M of funding over 2 rounds. Their latest funding round was raised on Feb 06, 2023 in the amount of $5.5M.

Section iconFunding & Financials

  • $5.5M

    cellvie has raised a total of $5.5M of funding over 2 rounds. Their latest funding round was raised on Feb 06, 2023 in the amount of $5.5M.

Company Leadership

  • Stylized image of a person
    S. H.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. B.
    Chief Operations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. S.
    Founder & Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. W.
    Research Scientist Ii And Laboratory Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    X. Y.
    Senior Scienitst
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.